Cyclopharm Limited Revises AGM Date and Director Nomination Deadline
I'm PortAI, I can summarize articles.
Cyclopharm Limited has revised the date for its Annual General Meeting to May 30, 2025, with director elections on the agenda. The new deadline for director nominations is April 9, 2025. This announcement, approved by CEO James McBrayer, is crucial for stakeholders as it outlines the company's governance timeline. Cyclopharm, an ASX-listed radiopharmaceutical company, focuses on improving patient care through its product, Technegas®, used for lung imaging. The company has a market cap of A$131.1M and a year-to-date price performance of -29.43%.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments